Muscle-zapping machines only help arthritic knees when paired with exercise

Knee osteoarthritis weakens the quadriceps partly because pain and joint problems inhibit the nervous system's ability to activate the muscle fully, a phenomenon known as arthrogenic muscle inhibition. Neuromuscular electrical stimulation, which contracts the muscle with electrical pulses delivered through skin electrodes, is widely used in rehabilitation to work around that inhibition. Individual randomised trials have disagreed about whether it actually improves the outcomes patients care about, so the overall clinical value of the technique has remained uncertain. This review pooled the trial evidence on pain, disability, strength and functional performance.

Following PRISMA 2020 guidance, the authors searched PubMed/MEDLINE, Embase, Scopus, Web of Science and CENTRAL from inception to April 2026 for randomised controlled trials of NMES in adults with knee osteoarthritis, delivered alone or in combination with exercise. Eight unique trials across ten publications qualified. Outcomes covered pain, self-reported disability, quadriceps strength, six-minute walk distance and Timed Up and Go performance, pooled with random effects models. Prespecified subgroup analyses tested whether results differed by comparator, and risk of bias was assessed with the standard Cochrane tool, with most trials rated at low risk or some concerns.

Overall, NMES did not significantly improve pain, self-reported disability, quadriceps strength or six-minute walk distance compared with the pooled comparator interventions. The one significant overall result, an improvement in Timed Up and Go performance, was largely driven by a single trial and deserves caution. The subgroup analyses proved more informative: NMES combined with exercise produced greater pain reduction than exercise alone, whereas NMES showed no consistent advantage when compared with alternative conservative interventions. The pattern suggests the technique's value depends heavily on the context in which it is delivered.

Previous trials pointed in different directions, and this pooled analysis explains part of the disagreement: the comparator matters. As a stand-alone therapy, NMES has little to show here; as an adjunct to structured exercise, it added measurable pain relief. That fits the rationale behind the device, which is to boost activation in muscles that inhibition prevents exercise alone from reaching fully. The evidence base remains thin, with only eight trials and varying stimulation protocols, and the authors call for larger, methodologically rigorous studies with standardised protocols to define who benefits most.

If you have osteoarthritic knees and have been offered electrical stimulation, the useful distinction is between replacement and supplement. Nothing here supports using a stimulation device instead of exercise, and its performance against other conservative options was inconsistent. Layered on top of a structured exercise programme, though, it was linked with greater pain reduction than exercise alone. With only eight trials behind these conclusions, expectations should stay modest until bigger studies clarify which patients gain the most.